Cargando…
The Application of Radiolabeled Targeted Molecular Probes for the Diagnosis and Treatment of Prostate Cancer
Radiopharmaceuticals targeting prostate-specific membrane antigens (PSMA) are essential for the diagnosis, evaluation, and treatment of prostate cancer (PCa), particularly metastatic castration-resistant PCa, for which conventional treatment is ineffective. These molecular probes include [(68)Ga]PSM...
Autores principales: | Cheng, Luyi, Yang, Tianshuo, Zhang, Jun, Gao, Feng, Yang, Lingyun, Tao, Weijing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248352/ https://www.ncbi.nlm.nih.gov/pubmed/37271211 http://dx.doi.org/10.3348/kjr.2022.1002 |
Ejemplares similares
-
FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors
por: Yang, Tianshuo, et al.
Publicado: (2022) -
Radiolabeled Liposomes for Nuclear Imaging Probes
por: Low, Ho Ying, et al.
Publicado: (2023) -
Targeting prostate cancer with radiolabelled bombesins
por: Maina, Theodosia, et al.
Publicado: (2006) -
Solitary Fibrous Tumor of the Prostate Shown on FAPI PET/CT
por: Yang, Tianshuo, et al.
Publicado: (2023) -
Imaging Bacteria with Radiolabelled Probes: Is It Feasible?
por: Signore, Alberto, et al.
Publicado: (2020)